HMGB1信号通路在支气管哮喘中作用的研究进展

doi:10.16352/j.issn.1001-6325.2023.04.0690

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (4): 690-694.doi: 10.16352/j.issn.1001-6325.2023.04.0690

HMGB1信号通路在支气管哮喘中作用的研究进展

孙莹¹, 杨治安¹, 何瑶¹, 余勤^2*

1.兰州大学第一临床医学院,甘肃兰州 730000;
2.兰州大学第一医院呼吸科,甘肃兰州 730000

收稿日期:2021-12-31 修回日期:2022-05-31 出版日期:2023-04-05 发布日期:2023-04-03
通讯作者: ^*yuq701@163.com
基金资助:
甘肃省科技计划(18YF1FA106)

Research progress on the role of HMGB1 signal pathway in bronchial asthma

SUN Ying¹, YANG Zhian¹, HE Yao¹, YU Qin^2*

1. the First School of Clinical Medcine, Lanzhou University, Lanzhou 730000;
2. Department of Respiratory, the First Hospital of Lanzhou University,Lanzhou 730000,China

Received:2021-12-31 Revised:2022-05-31 Online:2023-04-05 Published:2023-04-03
Contact: ^*yuq701@163.com

摘要/Abstract

摘要： 高迁移率族蛋白B1(HMGB1) 作为一种普遍存在的核蛋白,几乎在所有细胞中都有表达,激活释放后与其受体结合介导肺部炎性反应。HMGB1信号通路与支气管哮喘疾病的发生发展息息相关,相关的靶向药物治疗相继在动物实验以及临床试验中开展。

关键词: 高迁移率族蛋白B1 , 支气管哮喘, 气道炎性反应, 气道重塑

Abstract: High mobility group box 1 protein (HMGB1), as a ubiquitous nuclear protein, expresses in almost all cells. After activation and release, HMGB1 binds to its receptor and mediates pulmonary inflammatory response. HMGB1 signaling pathway is closely related to the occurrence and development of bronchial asthma. Related targeted drug therapy has been carried out in animal test and in clinical trials.

Key words: HMGB1, bronchial asthma, airway inflammation, airway remodeling

中图分类号:

R563.9

孙莹, 杨治安, 何瑶, 余勤. HMGB1信号通路在支气管哮喘中作用的研究进展[J]. 基础医学与临床, 2023, 43(4): 690-694.

SUN Ying, YANG Zhian, HE Yao, YU Qin. Research progress on the role of HMGB1 signal pathway in bronchial asthma[J]. Basic & Clinical Medicine, 2023, 43(4): 690-694.

参考文献

[1]Vanpatten S, Alabed Y.High mobility group box-1 (HMGb1): current wisdom and advancement as a potential drug target[J]. 2018, 61: 5093-5107.
[2]Zhao J, Sun T, Wu S, et al. High mobility group box 1: an Immune-regulatory protein[J]. 2019, 19: 100-109.
[3]Deng M, Scott M J, Fan J, et al.Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation[J]. J Leukocyte Biol, 2019, 106: 161-169.
[4]Scaffidi P, MisteliI T, Bianchi ME. Erratum: release of chromatin protein HMGB1 by necrotic cells triggers inflammation[J]. Nature,2002, 418: 191-195.
[5]Qu D, Ling Z, Tan X, et al. High mobility group protein B1 (HMGB1) interacts with receptor for advanced glycation end products (RAGE) to promote airway smooth muscle cell proliferation through ERK and NF-κB pathways[J]. Int J Clin Exp Pathol, 2019, 12: 3268-3278.
[6]Zhu X, Cong J, Yang B, et al. Association analysis of high-mobility group box-1 protein 1 (HMGB1)/toll-like receptor (TLR) 4 with nasal interleukins in allergic rhinitis patients[J]. Cytokine, 2020, 126:154880.
[7]Brandt EB, Lewkowich IP. RAGE-induced asthma: a role for the receptor for advanced glycation end-products in promoting allergic airway disease[J]. J Allergy Clin Immunol, 2019, 144: 651-653.
[8]Soliman NA, Abdel Ghafar MT, El Kolaley RM, et al. Cross talk between Hsp72, HMGB1 and RAGE/ERK1/2 signaling in the pathogenesis of bronchial asthma in obese patients[J]. Mol Biol Rep, 2020, 47: 4109-4116.
[9]Loh Z, Simpson J, Ullah A, et al. HMGB1 amplifies ILC2-induced type-2 inflammation and airway smooth muscle remodelling[J]. PLoS Pathogens, 2020, 16: e1008651.doi:10.1371/journal.ppat.1008651.
[10]Zhang F, Su X, Huang G, et al. sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells[J]. Sci Rep, 2017, 7: 14268.doi:10.1038/s41598-017-14667-4.
[11]Arikkatt J, Ullah MA, Short KR, et al. RAGE defici-ency predisposes mice to virus-induced paucigranulocytic asthma[J]. eLife, 2017,6:e21199.doi:10.7554/eLife.21199.
[12]Zhang X, Xie J, Sun H, et al. sRAGE inhibits the mucus hypersecretion in a mouse model with neutrophilic asthma[J]. Immunol Invest, 2022,51:1243-1256.
[13]Tang H, Li T, Han X, et al. TLR4 antagonist ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing inflammatory monocytes infiltration in mice model[J]. Int Immunopharmacol, 2019,73:254-260.
[14]Tang H, Han X, Li T, et al. Protective effect of miR-138-5p inhibition modified human mesenchymal stem cell on ovalbumin-induced allergic rhinitis and asthma syndrome[J]. J Cell Mol Med, 2021, 25: 5038-5049.
[15]Liu T, Barrett NA, Kanaoka Y, et al. Cysteinyl leuko-triene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism[J]. Mucosal Immunol, 2019, 12: 679-690.
[16]Liu M, Shan M, Zhang Y, et al. Progranulin protects against airway remodeling through the modulation of autophagy via HMGB1 suppression in house dust mite-induced chronic asthma[J]. J Inflamm Res, 2021, 14:3891-3904.
[17]Yang N, Shang YX. Epigallocatechin gallate ameliorates airway inflammation by regulating Treg/Th17 imbalance in an asthmatic mouse model [J]. Int Immunopharmacol, 2019, 72:422-428.
[18]Li Y, Chen L, Guo F, et al. Effects of epigallocatechin-3-gallate on the HMGB1/RAGE pathway in PM2.5-exposed asthmatic rats[J]. Biochem Biophys Res Commun, 2019, 513: 898-903.
[19]Gu X, Shu D, Ying S, et al. Roxithromycin attenuates inflammation via modulation of RAGE-influenced calpro-tectin expression in a neutrophilic asthma model[J]. Ann Transl Med, 2021, 9: 494.doi:10.21037/atm-21-859.
[20]Allam V, Faiz A, Lam M, et al. RAGE and TLR4 differentially regulate airway hyperresponsiveness: Implications for COPD[J]. Allergy, 2021, 76: 1123-1135.
[21]Zhang H, Yang N, Wang T, et al. Vitamin D reduces inflammatory response in asthmatic mice through HMGB1/TLR4/NF-κB signaling pathway[J]. Mol Med Rep, 2018, 17: 2915-2920.
[22]Lu M, Litonjua AA, Oconnor GT, et al. Effect of early and late prenatal vitamin D and maternal asthma status on offspring asthma or recurrent wheeze[J]. J Allergy Clin Immunol, 2021, 147: 1234-1241.
[23]Forno E, Bacharier LB, Phipatanakul W, et al. Effect of vitamin D₃ supplementation on severe asthma exacerba-tions in children with asthma and low vitamin D levels: the VDKA randomized clinical trial[J]. JAMA, 2020, 324: 752-760.
[24]Shang J, Liu W, Yin C, et al. Cucurbitacin E ameliorates lipopolysaccharide-evoked injury, inflammation and MUC5AC expression in bronchial epithelial cells by restraining the HMGB1-TLR4-NF-κB signaling[J]. Mol Immunol, 2019, 114:571-577.
[25]Wang X, Gap Y, Yang Q, et al. Pingchuanning decoction attenuates airway inflammation by suppressing autophagy via phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in rat models of asthma[J]. J Cell Biochem, 2019, 120: 3833-3844.

HMGB1信号通路在支气管哮喘中作用的研究进展

Research progress on the role of HMGB1 signal pathway in bronchial asthma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 8

编辑推荐

Metrics

本文评价

[1]	刘芬, 胡润芳, 茅松, 徐敏, 石文静, 陈凌. 地塞米松减轻过敏性哮喘模型小鼠气道炎性反应[J]. 基础医学与临床, 2023, 43(3): 402-407.
[2]	秦玉春, 邝向东, 蔡林再, 谢景臣, 陈山. 双氢青蒿素减轻慢性阻塞性肺疾病(COPD)模型大鼠肺损伤[J]. 基础医学与临床, 2023, 43(3): 427-432.
[3]	黄华, 周龙, 姚迪, 许诣. LncRNA PVT1 通过调节miR-214/STAT6 轴减轻哮喘模型小鼠气道炎性反应[J]. 基础医学与临床, 2022, 42(9): 1374-1380.
[4]	钟金鹏, 杨莉, 王辉波, 陈红健, 李金伟, 文明洪, 吕云波. HMGB1减弱丹参酮ⅡA对大鼠心肌缺血/再灌注损伤的缓解作用[J]. 基础医学与临床, 2022, 42(9): 1333-1338.
[5]	陈振宇, 黄启林, 孙红玉, 刘立业, 文艺. 腹腔穿刺引流对早期重症急性胰腺炎大鼠肝脏TLR4表达的影响[J]. 基础医学与临床, 2020, 40(10): 1342-1347.
[6]	吴晓娟余倩李敏超. 气道内高压力促进3种气道重塑相关因子的表达[J]. 基础医学与临床, 2017, 37(6): 763-767.
[7]	陶韬朱小华古嫦英张孝彬郭武廖秀清. ADAM33在IL-4刺激的人气道平滑肌细胞中对NF-κB和TGF-β1表达的影响[J]. 基础医学与临床, 2014, 34(10): 1391-1396.
[8]	林立李昌崇苏苗赏管小俊张维溪王晓丽罗运春. JNK磷酸化在哮喘大鼠肺内的动态变化[J]. 基础医学与临床, 2008, 28(2): 189-190.